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SUMMARY  
 
Mitochondrial dysfunction has been linked with both cellular senescence and 
ageing. Despite the relationship it is still unclear whether mitochondria has a 
causal role in senescence. In this issue of The EMBO Journal, Correia-Melo 
et al (2016) combine targeted depletion of mitochondria with impairment of 
their biogenesis to demonstrate that decreased mitochondria impairs the 
senescence response. Their results suggest that targeting mitochondria could 
reduce the detrimental effects of senescence during ageing 
 
MAIN TEXT 
 
Cellular senescence is a stress response in which damaged or aging cells 
stop proliferating and undergo distinct changes in their transcription, 
chromatin organization and metabolism. Senescent cells also produce a 
complex mix of secreted factors including matrix metalloproteinases, growth 
factors and pro-inflammatory cytokines, collectively termed the senescence-
associated secretory phenotype (SASP) (Salama et al, 2014). The importance 
of mitochondria in cellular senescence has been linked to their ability to 
generate reactive oxygen species (ROS). ROS can affect cellular senescence 
by inducing or stabilising a DNA damage response (DDR) that leads to a 
permanent growth arrest. However, little is known about how mitochondrial 
ROS affect other features of senescence like the SASP. Moreover, the role of 
mitochondria in senescence extends beyond ROS production and other 
sources of ROS can also be important for the development of senescence. 
Therefore, it needs to be clarified whether mitochondria can be effectors of 
senescence, and if so, by which mechanisms. 
 
Passos and colleagues (Correia-Melo et al, 2016) illuminated this matter by 
studying senescence in fibroblasts lacking mitochondria. This was achieved 
by taking advantage of an ingenious approach: Parkin-mediated mitophagy 
allows the generation of cells that are viable but depleted of mitochondria 
(Narendra et al, 2008). Using this and complementary approaches, the 
authors found that the absence of mitochondria affects multiple features of 
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senescence induced by ionizing radiation, such as the production of ROS and 
the SASP. Moreover, many transcriptional changes observed during 
senescence were reversed upon depletion of mitochondria. Paradoxically, the 
reduction in the expression of the cell cycle inhibitors p16INK4a and p21CIP1 was 
not sufficient to rescue cell proliferation. 
 
This impairment of senescence was not due to insufficient energy production. 
Indeed, senescent cells lacking mitochondria displayed higher ATP levels due 
to increased glycolysis. Therefore, the execution of the senescence program 
does not depend on ATP levels per se, but rather on the status of 
mitochondrial oxidative metabolism. This is in agreement with previous results 
from the Peeper’s lab, which reported that an increase of mitochondrial 
respiration through activation of pyruvate dehydrogenase (PDH) was required 
for the execution of oncogene-induced senescence (OIS) (Kaplon et al, 2013). 
Importantly, Kaplon et al also showed that senescence could be reversed in 
primary fibroblasts by blocking this OIS-specific metabolic rewiring towards 
mitochondrial oxidative metabolism.  
 
Mitochondrial mass and mitochondrial oxidation control the senescence 
phenotype, but the mechanisms have remained elusive. Passos and 
colleagues identify a novel pathway which links the DDR with increased 
mitochondrial mass through transcriptional activation of the mitochondrial 
biogenesis regulator PGC-1!. This increase in mitochondrial mass is 
dependent on ATM, AKT and mTORC1. Therefore, the authors propose a 
model in which the engagement of the DDR by different senescent triggers 
initiates a positive feedback loop that drives mTOR activation, PGC-1!–
dependent mitochondrial biogenesis and ROS production. The production of 
ROS maintains the persistent activation of the DDR, stabilizing cellular 
senescence and its pro-oxidant and pro-inflammatory phenotypes (Fig 1).  
 
Mitochondria and cellular senescence are important contributors to aging and 
age-related disease (Lopez-Otin et al, 2013)., Therefore, Passos and 
colleagues also looked for links between mitochondrial content and 
senescence during ageing (Correia-Melo et al, 2016). In agreement with their 
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in vitro results, they observed that increased DNA damage in aged 
hepatocytes correlates with higher mitochondrial content in an mTOR-
dependent fashion. Interestingly, Correia-Melo et al suggest that the inhibition 
of mTOR, which is know to increase lifespan in mice (Harrison et al, 2009), 
alleviates the age-promoting features of senescence by affecting 
mitochondrial mass rather than mitochondrial function.   
 
Since mTOR controls many processes, ranging from protein translation to 
lipid biosynthesis, its effects on lifespan are probably multifactorial. Among 
those, the ability of mTOR to control the senescent secretome could explain 
some of its effects in ageing. The authors propose here that mTOR could 
regulate the SASP via a complex pathway that involves mitochondrial 
biogenesis, ROS production, and increased DNA damage (Correia-Melo et al, 
2016). Eventually this activates NF-!B to induce the SASP. On the other 
hand, recent work suggests that mTOR controls the translation of known 
SASP regulators such as MAPKAPK2 (a kinase downstream of p38) (Herranz 
et al, 2015) or IL1A (Laberge et al, 2015) to directly regulate the SASP. What 
is the relative contribution of these and other still undiscovered mechanisms 
by which mTOR can control the SASP will have to be established. 
 
Previously, the role of mitochondria in ageing has been associated with the 
accumulation of dysfunctional mitochondria. In this regard it was recently 
shown that mitochondrial defects, often associated with ageing, can 
themselves cause a distinct type of senescence termed MiDAS (mitochondrial 
dysfunction-associated senescence) (Wiley et al, 2015). Adding to this, the 
present study suggests that increased mitochondrial mass may also drive 
age-related diseases and senescence phenotypes.  
 
It is now apparent that in addition to being a central part of the metabolic 
reprogramming occurring during senescence (Kaplon et al, 2013), 
mitochondria can both induce (Wiley et al, 2015) and mediate (Correia-Melo 
et al, 2016) senescence, so it will be necessary to integrate all these different 
observations. Moreover, a recent study has shown that autophagy contributes 
to maintain muscle function during ageing by preventing senescence (Garcia-
! 5 
Prat et al, 2016). Interestingly, the main consequence of autophagy loss is the 
accumulation of dysfunctional mitochondria and ROS due to defective 
mitophagy (Garcia-Prat et al, 2016). Therefore identifying ways of targeting 
mitochondria could be useful to design novel therapies to treat the many age-
related pathologies in which senescence plays a role.  
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FIGURE LEGEND  
 
 
Figure 1. Mitochondria are important effectors of the senescence 
response. Passos and Colleagues (Correia-Melo et al, 2016) describe that 
mitochondria form part of an autoregulatory loop involving the DNA damage 
response (DDR), mTOR and the production of ROS that results in persistent 
DDR and has a stabilizing effect on senescence. 
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